Clinical Trial Update: The Effect of Plasma Osmolality on Brain Glutamate [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the effect of plasma osmolality on brain glutamate levels in schizophrenia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Yale University | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED